ADPT Exercise Disclosure
Rubinstein Julie · SEC Form 4 · Filed Oct 21, 2026
Exercise
Calculated transaction value
$144.24K
Rubinstein Julie President And COO
Transaction date
Oct 21, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed same day
ADPT daily price context
Close on/before transaction
$25.33
Oct 21, 2026
First close after public filing
$24.41
Oct 22, 2026
Return after filing · so far
+22.2%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,881 shares @ $12.14
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001780664-26-000043
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$1.31M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 21, 2026 | $150.4K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 21, 2026 | $151.47K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 21, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT Current | Exercise | Oct 21, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 20, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 20, 2026 | $2.48K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 20, 2026 | $288.99K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 20, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 19, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 19, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 19, 2026 | $285.74K |